Showing 161 - 180 results of 16,814 for search '"cancers"', query time: 0.12s Refine Results
  1. 161
  2. 162
  3. 163

    Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study by Taylor Davis, Katherine T. Decker, Dana Hosseini, Gayle Jameson, Erkut Borazanci

    Published 2025-02-01
    “…While recent studies have explored the microbiome’s role in various types of cancer compared to healthy patients, this pilot study is the first to investigate differences in the skin microbiome composition among pancreatic adenocarcinoma patients, individuals with other cancers, and cancer-free controls.MethodsThe study characterizes the skin microbiome’s potential associations with cancer status by analyzing skin swabs from the forehead and cheek of 58 participants using Next Generation Sequencing (NGS), differential abundance analysis, and machine learning techniques.ResultsThe study results indicated that the cancer group displayed a significantly higher mean alpha diversity compared to the control group. …”
    Get full text
    Article
  4. 164

    Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient by Tsukasa Yasuda, Junji Hiraga, Michihiko Narita, Yoshimasa Tanikawa, Tomoyuki Tsuzuki

    Published 2021-01-01
    “…The case of a 76-year-old man with multiple primary cancers that were treated with nivolumab is presented. …”
    Get full text
    Article
  5. 165
  6. 166
  7. 167
  8. 168

    Clinicopathological Features of Advanced Gastric Cancers which Were Misjudged and Subjected to Endoscopic Submucosal Dissection by Yorinari Ochiai, Daisuke Kikuchi, Naoko Inoshita, Junnosuke Hayasaka, Yugo Suzuki, Masami Tanaka, Kosuke Nomura, Hiroyuki Odagiri, Satoshi Yamashita, Akira Matsui, Toshiro Iizuka, Masanobu Kitagawa, Shu Hoteya

    Published 2020-01-01
    “…Endoscopic submucosal dissection (ESD) is widely performed for early gastric cancer (EGC). We have sometimes encountered gastric cancer lesions for which ESD was performed and at which pathologically advanced cancer was found. …”
    Get full text
    Article
  9. 169

    Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease by Jie Li, Yonghong Liu, Jian Jin, Qingfeng Shi, Yanting Ji, Bo Zhang, Pengfei Hu

    Published 2023-01-01
    “…To explore the clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease. Method. An analytic approach of the reviewing method was adopted to analyze the clinical data of 80 breast cancer patients who were admitted to our hospital from January 2020 to January 2022. …”
    Get full text
    Article
  10. 170
  11. 171

    Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials by Nikolas Naleid, Amit Mahipal, Sakti Chakrabarti

    Published 2025-01-01
    “…<b>Background/Objectives:</b> Pembrolizumab, an immune checkpoint inhibitor targeting programmed death 1 (PD-1), is a widely employed therapy for various gastrointestinal (GI) cancers. We conducted a systematic review of clinical trials investigating pembrolizumab monotherapy in GI cancer patients to assess the spectrum and incidence of immune-related adverse events (irAEs) associated with pembrolizumab. …”
    Get full text
    Article
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180

    Longitudinal investigation of albumin-to-globulin ratio for human cancers demonstrates benefit in postoperative serial remeasurement by Zhenhui Li, Chunxia Li, Ruimin You, Yanli Li, Lizhu Liu, Hongjiang Pu, Ming Lei, Wenliang Li, Tao Zhang, Dingyun You

    Published 2025-01-01
    “…Abstract Previous studies on serum albumin-to-globulin ratio (AGR) in human cancers were limited to its preoperative level, with postoperative serial AGR remeasurements ignored. …”
    Get full text
    Article